Computerized Cognitive Training for Psychosis
(Rem-STEP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two types of computerized brain training to help individuals with psychosis better process information about their surroundings. One group will engage in exercises to enhance their ability to see and understand visual information, while the other will focus on controlling and stabilizing visual information. These exercises are part of the BrainHQ Computerized Cognitive Training, specifically the Visual Cognitive Control Training Paradigm and the Visual Perception Training Paradigm. Ideal candidates are young adults aged 18-30 with diagnoses such as schizophrenia or bipolar disorder with psychotic features, who have not been hospitalized for psychiatric reasons in the past month. Participants must speak and understand English fluently, have access to a computer, and reside in the United States. As an Early Phase 1 trial, this research aims to understand how the treatment works in people, offering participants a chance to contribute to groundbreaking research.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. It is best to discuss this with the study team or your healthcare provider.
What prior data suggests that this computerized cognitive training is safe for individuals with psychosis?
A previous study found computerized brain training to be an effective and safe method for people with schizophrenia, reducing impulsive aggression and indicating good tolerance. Another study showed similar training improved thinking skills in people with mild cognitive impairment (MCI) and healthy individuals, suggesting its effectiveness across different groups without harm.
Research has shown that technology-based training like BrainHQ effectively improves thinking skills. Large studies have used this training safely. Evidence also indicates that using devices like tablets for this training is practical and does not cause serious side effects.
Since this trial is in an early phase, researchers are closely monitoring safety. Early phases focus on ensuring the treatment's safety for participants. These findings suggest the treatments are generally safe and well-tolerated, but safety will be carefully observed in this trial.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments because they offer a novel approach to managing psychosis by directly targeting cognitive processes. Unlike traditional treatments for psychosis that often rely on medications to manage symptoms, these therapies use BrainHQ's computerized cognitive training paradigms to enhance specific brain functions. The Visual Perception Training focuses on improving how the brain processes visual information at the perceptual level, while the Visual Cognitive Control Training aims to stabilize how the brain represents visual information. This innovative, non-pharmacological method could complement existing treatments and potentially improve cognitive functions in those with psychosis.
What evidence suggests that this trial's treatments could be effective for psychosis?
Research has shown that BrainHQ's Visual Perception Training, one of the treatment arms in this trial, can improve thinking skills for people with psychosis. In previous studies, participants experienced better emotional understanding and social interactions. These exercises help the brain process information more efficiently, which is crucial for those with schizophrenia.
Similarly, BrainHQ's Visual Cognitive Control Training, another treatment arm in this trial, has shown positive results. Studies found that it improves thinking and memory. This training may help the brain manage visual information better, benefiting people with psychosis. Evidence supports both methods as offering new ways to address thinking challenges in schizophrenia.678910Who Is on the Research Team?
Caroline Demro, PhD
Principal Investigator
University of Minnesota Department of Psychiatry and Behavioral Sciences
Are You a Good Fit for This Trial?
This trial is for individuals aged 18-45 with conditions like schizophrenia or mood disorders with psychotic features, fluent in English, and have been stable outside a hospital for at least a month. They must not have severe substance use recently, significant cognitive training experience within the last six months, or other neurological disorders (except autism).Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Cognitive Training
Participants undergo either visual perception training or visual cognitive control training to improve state representation processes
Follow-up
Participants are monitored for changes in cognitive performance and symptoms post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- BrainHQ Computerized Cognitive Training - Visual Cognitive Control Training Paradigm
- BrainHQ Computerized Cognitive Training - Visual Perception Training Paradigm
BrainHQ Computerized Cognitive Training - Visual Cognitive Control Training Paradigm is already approved in United States, European Union for the following indications:
- Cognitive training for individuals with psychotic illnesses
- General cognitive improvement
- Cognitive training for individuals with psychotic illnesses
- General cognitive improvement
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator